 New York, New York--Newsfile Corp. - April 8, 2021 - PCG Digital -- The team at Lexaria Bioscience NASDAQ: LEXX, a leader in cannabinoid research, has been thinking outside the box. Utilizing DehydraTECHTM, their proprietary drug delivery technology, they are showing that its benefits can enrich more than just CBD medical applications.Though they are currently executing groundbreaking work in anti-hypertension solutions, Lexaria received their first patent in 2016 for CBD-infused beverages and consumable liquids. That... 